USPTO serial 79303109
MERLIN
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 9, 2021
- Examiner
- RUTLAND, BARBARA A
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with MERLIN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medical molecular diagnostic test reagents; medical molecular diagnostic test reagents of body substances, such as bone marrow samples, blood samples, and on human or animal tissue; molecular diagnostic test reagents for cancer for medical purposes; medical molecular diagnostic test reagents, inter alia on the basis of microarray technology and sequencing technology; reagents for use in medical genetic testing; reagents for use in medical genetic testing for the measurement of the gene expression profile; reagents for use in medical genetic testing for the measurement of gene aberrations and mutations; clinical diagnostic test reagents for determination of genetic sub-type of a patient; medical prognostic test reagents for testing of bodily fluids for use in disease detection, namely oncology; predictive test reagents, in search of the effectiveness of a medical treatment and/or to select the medical treatment; diagnostic test reagents and preparations for medical or veterinary purposes; chemical preparations, for medical purposes, for the testing of blood and human or animal tissue, including cancer cells; medical diagnostic test strips for tissue-based diagnostics; diagnostic testing materials for medical use, namely medical diagnostic reagents and assays for testing of tissue for use in disease detection, namely oncology; preparations for detecting mutation in human genes for medical purposes | ACTIVE | — |
| 042 | Research and development of new products for others; biochemical research and development; pharmaceutical research and development; research and development in the field of diagnostic preparations; biological research, clinical research provided via a website and medical research; scientific research for the benefit of the development of molecular diagnostic tests; analysis and evaluation of results from quality control tests of the goods of others to determine conformity with certification standards; molecular diagnostic analysis; investigation and analysis of body substances and molecular diagnostic test scores for the purpose of the development of new biomarkers; development and diagnostic testing of treatment methods for scientific research for medical purposes; development and testing services for the certification of quality or standards of molecular diagnostic tests; computer aided diagnostic testing services for others in the fields of science and research related thereto; scientific research for medical purposes in the area of cancerous diseases; genetic testing for scientific research purposes; research of pharmaceutical preparations in the field of gene therapy; providing information about medical research in the field of diagnostic testing services in the field of skin cancer | ACTIVE | — |
| 044 | Medical analysis services for diagnostic and treatment-decision purposes provided by medical laboratories; medical analysis services for diagnostic and treatment-decision purposes provided by medical laboratories using test scores and data for medical or veterinary purposes for others; medical and veterinary information services provided via the internet; medical testing for diagnostic or treatment purposes; medical diagnostic testing, monitoring and reporting services; medical analysis services for cancer diagnosis and prognosis; medical services for the treatment of skin cancer; medical analysis services for the diagnosis of cancer | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by SkylineDx B.V.
- Other trademarks owned by SkylineDx B.V.
- Other trademarks owned by SkylineDx B.V.
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named MERLIN
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 24, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 1, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 1, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 9, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 9, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 24, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 24, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 22, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Aug 4, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 4, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Aug 4, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 16, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 9, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 8, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 8, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 25, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 6, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 6, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 31, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 30, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 26, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 2, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 29, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 28, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |